Synexus to double trial capacity in South Africa

UK-headquartered Synexus is planning to more than double its clinical trial capacity in South Africa through the expansion of its Pretoria facilities and by opening two purpose-designed sites, one in Mamelodi and one in Soshanguwe.

Synexus, which is involved in the recruitment and running of clinical trials, hopes to have the new sites completed by March 2009. The company, which acquired the clinical trial business CRC SA in 2006, says it has found South Africa to be an excellent place to undertake this kind of work across a wide variety of therapy areas and phases.

Chief executive Michael Fort commented: "South Africa has proven to be one of our most successful sites both in terms of achieving high numbers of patients and also in the quality of the trials carried out. We will continue to expand our presence in South Africa."